Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

HUMA

Humacyte, Inc.

CIK 0001818382 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.64
↓ 0.04 (-5.75%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Technicals

Key stats

Market Cap
$173.16M
P/E Ratio
-1.79
EPS
-0.26
Dividend Yield
Not covered
52W Position
6%
Beta
3.14

Valuation multiples

Fwd P/E
35.84
PEG
Not covered
P/B
5.54
P/S
81.64
EV/Revenue
61.10
ROE
-309.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$0.53$2.55

Latest Financials

2025-12-31 FY
Revenue
$2.04M
Net Income
-$40.83M
Total Assets
$116.37M
Free Cash Flow
-$105.93M

Recent news